D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 58 Citations 12,193 136 World Ranking 8843 National Ranking 650

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • DNA

The scientist’s investigation covers issues in Cancer research, Cell biology, Androgen receptor, KDM1A and Molecular biology. His Cancer research study integrates concerns from other disciplines, such as Histone H3, Histone, Demethylase, Coactivator and Nuclear receptor. His studies deal with areas such as Syndecan 1, Cadherin, Retinoic acid receptor alpha, Retinoid X receptor and Retinoid X receptor alpha as well as Cell biology.

His biological study focuses on RNF4. The KDM1A study combines topics in areas such as Progenitor cell, Stem cell and Myeloid leukemia, Immunology. His research integrates issues of Cranial neural crest and Regulation of gene expression in his study of Molecular biology.

His most cited work include:

  • LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. (1383 citations)
  • Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. (495 citations)
  • Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. (418 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Cancer research, Cell biology, Demethylase, Biochemistry and Molecular biology. The concepts of his Cancer research study are interwoven with issues in Prostate cancer, Androgen receptor, FHL2 and Epigenetics. His Androgen receptor research includes themes of Coactivator and Nuclear receptor.

His Cell biology course of study focuses on Histone code and Histone demethylation. Roland Schüle has researched Demethylase in several fields, including Histone H3, Histone methyltransferase and Histone methylation. His Molecular biology research is multidisciplinary, incorporating perspectives in Enhancer, Histone acetyltransferase, Transcription factor, Transactivation and Promoter.

He most often published in these fields:

  • Cancer research (30.92%)
  • Cell biology (24.34%)
  • Demethylase (22.37%)

What were the highlights of his more recent work (between 2017-2020)?

  • Epigenetics (21.05%)
  • Cancer research (30.92%)
  • Cell biology (24.34%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Epigenetics, Cancer research, Cell biology, Regulation of gene expression and Cell cycle. The various areas that Roland Schüle examines in his Epigenetics study include Cancer, Receptor and Pharmacology. His research in Cancer research intersects with topics in Cytotoxic T cell and Breast cancer.

His Epidermis study in the realm of Cell biology interacts with subjects such as GLIS1. His study on Regulation of gene expression also encompasses disciplines like

  • Methylation, which have a strong connection to Effector, Histone code and Histone H4,
  • Prostate cancer, Methyllysine and Tudor domain most often made with reference to Chromatin. His research in Cell cycle focuses on subjects like Histone methyltransferase, which are connected to Drug discovery, HEK 293 cells, Adenocarcinoma and Lung cancer.

Between 2017 and 2020, his most popular works were:

  • Lsd1 regulates skeletal muscle regeneration and directs the fate of satellite cells. (24 citations)
  • KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells. (21 citations)
  • LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML. (21 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • DNA

The scientist’s investigation covers issues in Regulation of gene expression, Cell biology, Chromatin, Methylation and Transcription factor. His Regulation of gene expression research is multidisciplinary, incorporating elements of Myeloid and Cancer research. The Stem cell research he does as part of his general Cell biology study is frequently linked to other disciplines of science, such as GLIS1, therefore creating a link between diverse domains of science.

His study in Histone code and Histone lysine methylation are all subfields of Chromatin. The study incorporates disciplines such as Histone H4, Cell cycle, Prostate cancer and Effector in addition to Methylation. His Transcription factor study combines topics in areas such as Leukemia, Myeloid leukemia, Epigenetics and Cellular differentiation.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.

Eric Metzger;Melanie Wissmann;Na Yin;Judith M. Müller.
Nature (2005)

1883 Citations

Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.

Melanie Wissmann;Na Yin;Judith M. Müller;Holger Greschik.
Nature Cell Biology (2007)

767 Citations

Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology

Soyoung Lim;Andreas Janzer;Astrid Becker;Andreas Zimmer.
Carcinogenesis (2010)

562 Citations

FHL2, a Novel Tissue-Specific Coactivator of the Androgen Receptor

Judith M. Müller;Ulrike Isele;Eric Metzger;Annette Rempel.
The EMBO Journal (2000)

475 Citations

Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy

Johannes H. Schulte;Soyoung Lim;Alexander Schramm;Nicolaus Friedrichs.
Cancer Research (2009)

465 Citations

Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.

Philip Kahl;Lucia Gullotti;Lukas Carl Heukamp;Susanne Wolf.
Cancer Research (2006)

448 Citations

A TFTC/STAGA Module Mediates Histone H2A and H2B Deubiquitination, Coactivates Nuclear Receptors, and Counteracts Heterochromatin Silencing

Yue Zhao;Guillaume Lang;Saya Ito;Jacques Bonnet.
Molecular Cell (2008)

398 Citations

Phosphorylation of histone H3T6 by PKCβ I controls demethylation at histone H3K4

Eric Metzger;Axel Imhof;Dharmeshkumar Patel;Philip Kahl.
Nature (2010)

299 Citations

Cloning and characterization of a fourth human somatostatin receptor.

Lucia Rohrer;Friedrich Raulf;Christian Bruns;Reinhard Buettner.
Proceedings of the National Academy of Sciences of the United States of America (1993)

289 Citations

All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta.

Catherine Stehlin-Gaon;Dominica Willmann;Denis Zeyer;Sarah Sanglier.
Nature Structural & Molecular Biology (2003)

286 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Roland Schüle

Takayoshi Suzuki

Takayoshi Suzuki

Osaka University

Publications: 37

Wolfgang Sippl

Wolfgang Sippl

Martin Luther University Halle-Wittenberg

Publications: 35

Manfred Jung

Manfred Jung

University of Freiburg

Publications: 34

Ratna K. Vadlamudi

Ratna K. Vadlamudi

The University of Texas at Austin

Publications: 31

Hong-Min Liu

Hong-Min Liu

Zhengzhou University

Publications: 27

Andrea Mattevi

Andrea Mattevi

University of Pavia

Publications: 26

Saverio Minucci

Saverio Minucci

European Institute of Oncology

Publications: 26

Yang Shi

Yang Shi

Boston Children's Hospital

Publications: 24

Antonello Mai

Antonello Mai

Sapienza University of Rome

Publications: 23

Stefan Knapp

Stefan Knapp

Goethe University Frankfurt

Publications: 23

Martin Götte

Martin Götte

University of Münster

Publications: 22

Thomas Reinheckel

Thomas Reinheckel

University of Freiburg

Publications: 18

Shigeaki Kato

Shigeaki Kato

University of Tokyo

Publications: 18

Paul Brennan

Paul Brennan

International Agency For Research On Cancer

Publications: 18

Susanne Müller

Susanne Müller

Structural Genomics Consortium

Publications: 18

Sharon Y.R. Dent

Sharon Y.R. Dent

The University of Texas MD Anderson Cancer Center

Publications: 18

Trending Scientists

Yakov Amihud

Yakov Amihud

New York University

Thomas P. Lyon

Thomas P. Lyon

University of Michigan–Ann Arbor

Richard Ian Laming

Richard Ian Laming

Optoscribe Ltd.

Zhang Lin

Zhang Lin

South China University of Technology

Rosiane Lopes da Cunha

Rosiane Lopes da Cunha

State University of Campinas

Hiroki Kurahashi

Hiroki Kurahashi

Fujita Health University

Alexander Steinkasserer

Alexander Steinkasserer

University of Erlangen-Nuremberg

Elly M. Tanaka

Elly M. Tanaka

Research Institute of Molecular Pathology

Vesa Kaartinen

Vesa Kaartinen

University of Michigan–Ann Arbor

Michael A. Silverman

Michael A. Silverman

Children's Hospital of Philadelphia

Tavi Murray

Tavi Murray

Swansea University

Raffaele Manni

Raffaele Manni

University of Pavia

Maggie Shiffrar

Maggie Shiffrar

Rutgers, The State University of New Jersey

Johan Ärnlöv

Johan Ärnlöv

Karolinska Institute

Ellen R. Wald

Ellen R. Wald

University of Wisconsin–Madison

Eduardo Bonilla-Silva

Eduardo Bonilla-Silva

Duke University

Something went wrong. Please try again later.